Sitagliptin and Fractures in Type 2 Diabetes: A Nationwide Population-Based Propensity-Matching Study

• Main Authors: Shih-Yi Lin (Author), Wu-Huei Hsu (Author), Cheng-Chieh Lin (Author), Cheng-Li Lin (Author), Chun-Hao Tsai (Author), Hung-Chieh Yeh (Author), Chung-Y. Hsu (Author), Chia-Hung Kao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Sitagliptin, a dipeptidyl peptidase-4 inhibitor possibly affects bone turnover. We conducted this cohort study to determine whether sitagliptin is associated with an increased risk of fracture.Methods: The sitagliptin cohort included 1,578 patients aged 20 years and above. The nonsitagli...